202 related articles for article (PubMed ID: 15975686)
1. The questionable role of immunization against hepatitis B in HBV infected liver transplant patients.
Samuel D; Shouval D
J Hepatol; 2005 Aug; 43(2):203-6. PubMed ID: 15975686
[No Abstract] [Full Text] [Related]
2. Outcomes of passive-active immunoprophylaxis given to infants of mothers infected with hepatitis B virus in Babol, Iran.
Soleimani Amiri MJ; Hasanjani Roushan MR; Baiany M; Taheri H; Hasanjani Roushan M
J Clin Virol; 2010 Dec; 49(4):283-5. PubMed ID: 20846904
[TBL] [Abstract][Full Text] [Related]
3. The ways paved for prophylaxis against de novo hepatitis B virus infection after liver transplantation: still many stones left unturned.
Ni YH; Chang MH
Pediatr Transplant; 2006 Jun; 10(4):405-7. PubMed ID: 16712595
[No Abstract] [Full Text] [Related]
4. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
5. Primary transplant treatment of hepatitis B: hepatitis B immunoglobulin (passive immunization).
Pruett T
Liver Transpl Surg; 1997 Sep; 3(5 Suppl 1):S13-5. PubMed ID: 9377765
[No Abstract] [Full Text] [Related]
6. The status of immunity against the hepatitis B virus among vaccinated hemodialysis patients: a single center report from Iran.
Khamene ZR; Sepehrvand N
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):547-50. PubMed ID: 17951941
[TBL] [Abstract][Full Text] [Related]
7. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
Tabor E
J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
[TBL] [Abstract][Full Text] [Related]
8. [Vaccination. Hepatitis B].
Braun R; Kimmig P; Hassler D
Dtsch Med Wochenschr; 2002 May; 127(20):1062. PubMed ID: 12051190
[No Abstract] [Full Text] [Related]
9. Neutralization of hepatitis B virus (HBV) by human monoclonal antibody against HBV surface antigen (HBsAg) in chimpanzees.
Kim SH; Shin YW; Hong KW; Chang KH; Ryoo KH; Paik SH; Kim JM; Brotman B; Pfahler W; Prince AM
Antiviral Res; 2008 Sep; 79(3):188-91. PubMed ID: 18479762
[TBL] [Abstract][Full Text] [Related]
10. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
11. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B immunoglobulin: new preparation. Prolongs survival after liver transplantation.
Prescrire Int; 2003 Aug; 12(66):135-7. PubMed ID: 12906022
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
Bailey CL; Smith V; Sands M
Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
[TBL] [Abstract][Full Text] [Related]
14. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
[TBL] [Abstract][Full Text] [Related]
15. [Active and passive immunization against hepatitis B virus infection].
Colak H
Mikrobiyol Bul; 1982 Jan; 16(1):71-6. PubMed ID: 7144619
[TBL] [Abstract][Full Text] [Related]
16. [Vaccine prophylaxis of viral hepatitis B in patients with acute leukemia].
Gurina NM; Svedentsov EP; Shardakov VI; Cherepanova VV
Ter Arkh; 2008; 80(7):27-9. PubMed ID: 18763590
[TBL] [Abstract][Full Text] [Related]
17. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients: antibody decline and booster vaccination with conventional vaccine.
Günther M; Neuhaus R; Bauer T; Jilg W; Holtz JA; Bienzle U
Liver Transpl; 2006 Feb; 12(2):316-9. PubMed ID: 16447191
[TBL] [Abstract][Full Text] [Related]
18. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
Ijaz S; Khulan J; Bissett SL; Ferns RB; Nymadawa P; Tedder RS
J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic recombinant hepatitis B vaccine in patients undergoing orthotopic liver transplantation.
Berner J; Kadian M; Post J; Miller C; Schwartz M; Conn M; Borcich A
Transplant Proc; 1993 Apr; 25(2):1751-2. PubMed ID: 8470152
[No Abstract] [Full Text] [Related]
20. Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer.
Kaloyannidis P; Batsis I; Yannaki E; Adamidou D; Bartzoudis D; Papathanasiou M; Mallouri D; Sakellari I; Fassas A; Anagnostopoulos A
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1049-56. PubMed ID: 17697967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
